From Inflammation to Wound Healing: Using a Simple Model to Understand the Functional Versatility of Murine Macrophages

Bulletin of Mathematical Biology

Volumn 73, Issue 11, 2011, Pages 2575-2604

  Childs, Lauren M ^a,c   Paskow, Michael ^a,d   Morris Jr , Sidney M ^b   Hesse, Matthias ^a,e   Strogatz, Steven ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d ChanTest Corporation   (United States)

^e VERTEX PHARMACEUTICALS   (United States)

Author keywords

Inflammation; Macrophage activation; Ordinary differential equation (ODE) model; Wound repair

Indexed keywords

ANIMAL; ARTICLE; BIOLOGICAL MODEL; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MATHEMATICAL PHENOMENA; MOUSE; WOUND HEALING;

ANIMALS; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES; MATHEMATICAL CONCEPTS; MICE; MODELS, IMMUNOLOGICAL; WOUND HEALING;

MURINAE;

EID: 81255142093     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-011-9637-5     Document Type: Article

References (65)

1. Alarcón, R., Orellana, M. S., Neira, B., Uribe, E., García, J. R., & Carvajal, N. (2006). Mutational analysis of substrate recognition by human arginase type I-agmatinase activity of the N130D variant. FEBS J., 273, 5625-5631.
2. Albina, J. E., Mills, C. D., Henry, W. L. Jr, & Caldwell, M. D. (1990). Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J. Immunol., 144(10), 3877-3880.
3. Anthony, R. M., Rutitzky, L. I., Urban, J. F. Jr., Stadecker, M. J., & Gause, W. C. (2007). Protective immune mechanisms in helminth infection. Nat. Rev. Immunol., 7, 975-987.
4. 2+ regulates bacterial lipopolysaccharide induction of iNOS in human macrophages. Immunobiology, 214, 143-152.
5. Bogdan, C. (1997). Of microbes, macrophages and nitric oxide. Behring-Inst.-Mitt., 99, 58-72.
6. ω-hydroxy-L-arginine, an intermediate in the L-arginine to Nitric Oxide pathway, is a strong inhibitor of liver and macrophage Arginase. Biochem. Biophys. Res. Commun., 203, 1614-1621.
7. Boucher, J. L., Moali, C., & Tenu, J. P. (1999). Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell. Mol. Life Sci., 55, 1015-1028.
8. G-hydroxy-L-arginine: implications for the regulation of nitric oxide biosynthesis by arginase. Biochem. Biophys. Res. Commun., 202, 174-180.
9. Daley, J. M., Brancato, S. K., Thomay, A. A., Reichner, J. S., & Albina, J. E. (2010). The phenotype of murine wound macrophages. J. Leukoc. Biol., 87(1), 59-67.
10. El Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J., König, T., Schleicher, U., Koo, M. S., Kaplan, G., Fitzgerald, K. A., Tuomanen, E. I., Orme, I. M., Kanneganti, T. D., Bogdan, C., Wynn, T. A., & Murray, P. J. (2008). Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol., 9(12), 1399-1406.
11. El-Gayar, S., Thuring-Nahler, H., Pfeilschifter, J., Rollinghoff, M., & Bogdan, C. (2003). Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J. Immunol., 171(9), 4561-4568.
12. Fallon, P. G., & Mangan, N. E. (2007). Suppression of TH2-type allergic reactions by helminth infection. Nat. Rev. Immunol., 7, 220-230.
13. Gause, W. C., Urban, J. F. Jr., & Stadecker, M. J. (2003). The immune response to parasitic helminths: insights from murine models. Trends Immunol., 24, 269-277.
14. Goldsby, R. A., Kindt, T. J., & Osborne, B. A. (2002). Kuby immunology (4th ed.). New York: Freeman.
15. Gordon, S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol., 3, 23-35.
16. Gordon, S. (2007). The macrophage: past, present and future. Eur. J. Immunol., 37(1), S9-S17.
17. Gordon, S., & Martinez, F. O. (2010). Alternative activation of macrophages: mechanism and functions. Immunity, 32(5), 593-604.
18. Gotoh, T., & Mori, M. (1999). Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264. 7 cells. J. Cell Biol., 144, 427-434.
19. Gray, M. J., Poljakovic, M., Kepka-Lenhart, D., & Morris, S. M. Jr. (2005). Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. Gene, 353, 98-106.
20. G-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett., 359, 251-254.
21. Herald, M. C. (2010). General model of inflammation. Bull. Math. Biol., 72(4), 765-779.
22. Herbert, D. R., Holscher, C., Mohrs, M., Arendse, B., Schwegmann, A., Radwanska, M., Leeto, M., Kirsch, R., Hall, P., Mossmann, H., Claussen, B., Forster, I., & Brombacher, F. (2004). Alternative macrophage activation is essential for survival during schistosomiasis and down modulates T helper 1 responses and immunopathology. Immunity, 20, 623-635.
23. Hesse, M., Cheever, A. W., Jankovic, D., & Wynn, T. A. (2000). NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am. J. Pathol., 157(3), 945-955.
24. Hesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J., & Wynn, T. A. (2001). Differential regulation of nitric oxide synthase-2 and arginase-1 by type1/type2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol., 167, 6533-6544.
25. Janeway, C. A., Travers, P., Walport, M., & Shlomichik, M. (2001). Immunobiology (Vol. 5). New York: Garland.
26. Khallou-Laschet, J., Varthaman, A., Fornasa, G., Compain, C., Gaston, A.-T., Clement, M., Cussiot, M., Levillain, O., Graff-Dubois, S., Nicoletti, A., & Caligiuri, G. (2010). Macrophage plasticity in experimental atherosclerosis. PLoS ONE, 5(1), e8852.
27. Kolodziejski, P. J., Koo, J.-S., & Eissa, N. T. (2004). Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. Proc. Natl. Acad. Sci. USA, 101(52), 18141-18146.
28. Krieg, A. M. (2000). Signal transduction induced by immunostimulatory CpG DNA. Springer Semin. Immunopath, 22(1-2), 97-105.
29. Loehning, M., Hegazy, A. N., Pinschewer, D. D., Busse, D., Lang, K. S., Hofer, T., Radbruch, A., Sinkernagel, R. M., & Hengartner, H. (2008). Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J. Exp. Med., 205(1), 53-61.
30. MacMicking, J., Xie, Q. W., & Nathan, C. (1997). Nitric oxide and macrophage function. Annu. Rev. Immunol., 15, 323-350.
31. Maggelakis, S. A. (2003). A mathematical model of tissue replacement during epidermal wound healing. Appl. Math. Model., 27(3), 189-196.
32. Maggelakis, S. A. (2004). Modeling the role of angiogenesis in epidermal wound healing. Discrete Contin. Dyn. Syst., Ser. B, 4(1), 267-273.
33. Mahoney, E., Reichner, J., Bostom, L. R., Mastrofrancesco, B., Henry, W., & Albina, J. (2002). Bacterial colonization and the expression of inducible nitric oxide synthase in murine wounds. Am. J. Pathol., 161(6), 2143-2152.
34. Mansuy, D., & Boucher, J.-L. (2004). Alternative nitric oxide-producing substrates for NO synthases. J. Free Radic. Biol. Med., 37(8), 1105-1121.
35. Marée, A. F., Komba, M., Dyck, C., Labecki, M., Finegood, D. T., & Edelstein-Keshet, L. (2005). Quantifying macrophage defects in type 1 diabetes. J. Theor. Biol., 233(4), 533-551.
36. Marino, S., Myers, A., Flynn, J. L., & Kirschner, D. E. (2010). TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next-generation two-compartmental model. J. Theor. Biol., 265(4), 586-598.
37. Martinez, F. O., Sica, A., Mantovani, A., & Locati, M. (2008). Macrophage activation and polarization. Front. Biosci., 13, 453-461.
38. ω-hydroxynor-L-arginine. Biochemistry, 37, 10453-10460.
39. Moali, C., Brollo, M., Custot, J., Sari, M., Boucher, J.-L., Stuehr, D. J., & Mansuy, D. (2000). Recognition of α-amino acids bearing various C=NOH functions by nitric oxide synthase involves very different structural determinants. Biochemistry, 39, 8208-8218.
40. Modolell, M., Corraliza, I. M., Link, F., Soler, G., & Eichmann, K. (1995). Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol., 25(4), 1101-1104.
41. Morris, S. M. Jr., Kepka-Lenhart, D., & Chen, L. C. (1998). Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am. J. Physiol., 275(5 Pt 1), E740-E747.
42. Mosser, D. M. (2003). The many faces of macrophage activation. J. Leukoc. Biol., 73, 209-212.
43. Mosser, D. M., & Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol., 8(12), 958-969.
44. Munder, M., Eichmann, K., & Modolell, M. (1998). Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol., 160, 95347.
45. Nathan, C. (1994). Nitric oxide and biopterin: a study in Chairoscuro. J. Clin. Invest., 93(5), 2236-2243.
46. Ourgrinovskaia, A., Thompson, R. S., & Myerscough, M. R. (2010). An ODE model of early stages of atherosclerosis: mechanisms of the inflammatory response. Bull. Math. Biol., 72(6), 1534-1561.
47. Pauleau, A.-L., Rutschman, R., Lang, R., Pernis, A., Watowich, S. S., & Murray, P. J. (2004). Enhancer-mediated control of macrophage-specific arginase I expression. J. Immunol., 172, 7565-7573.
48. Pearce, E. J., & MacDonald, A. S. (2002). The immunobiology of schistosomiasis. Nat. Rev. Immunol., 2(7), 499-511.
49. Pesce, J., Kaviratne, M., Ramalingam, T. R., Thompson, R. W., Urban, J. F. Jr., Cheever, A. W., Young, D. A., Collins, M., Grusby, M. J., & Wynn, T. A. (2006). The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J. Clin. Invest., 116(7), 2044-2055.
50. Pettet, G. J., Byrne, H. M., Mcelwain, D. L. S., & Norbury, J. (1996). A model of wound-healing angiogenesis in soft tissue. Math. Biosci., 136(1), 35-63.
51. Porcheray, F., Viaud, S., Rimaniol, A. C., Leone, C., Samah, B., Dereuddre-Bosquet, N., Dormont, D., & Gras, G. (2005). Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol., 142, 481-489.
52. Reyes, J. L., & Terrazas, L. I. (2007). The divergent roles of alternatively activated macrophages in helminthic infections. Parasite Immunol., 29, 609-619.
53. Rutschman, R., Lang, R., Hesse, M., Ihle, J. N., Wynn, T. A., & Murray, P. J. (2001). Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol., 166(4), 2173-2177.
54. Santhanam, L., Christianson, D. W., Nyham, D., & Berkowitz, D. E. (2008). Arginase and vascular aging. J. Appl. Physiol., 105, 1632-1642.
55. Schreiber, R. D. (1984). Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity. Contemp. Top. Immunobiol, 13, 171-198.
56. Shin, D.-G., Kazmi, S. A., Pei, B., Kim, Y.-A., Maddox, J., Nori, R., Wong, A., Krueger, W., & Rowe, D. (2009). Computing consistency between microarray data and known gene regulation relationships. IEEE Trans. Inf. Technol. Biomed., 13(6), 1075-1082.
57. Stadecker, M. J., Asahi, H., Finger, E., Hernandez, H. J., Rutitzky, L. I., & Sun, J. (2004). The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol. Rev., 201, 168-179.
58. Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992). Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med., 176(1), 287-292.
59. Stout, R. D., & Suttles, J. (2004). Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol., 76, 509-513.
60. Stuehr, D. J. (1999). Mammalian nitric oxide synthases. Biochim. Biophys. Acta, 1411, 217-230.
61. Waugh, H. V., & Sherratt, J. A. (2006). Macrophage dynamics in diabetic wound healing. Bull. Math. Biol., 68(1), 197-207.
62. Wei, L. H., Jacobs, A. T., Morris, S. M. Jr., & Ignarro, L. J. (2000). IL-4 and IL-13 up-regulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am. J. Physiol., Cell Physiol., 279, 248-256.
63. Wendelsdorf, K., Bassaganya-Riera, J., Hontecillas, R., & Eubank, S. (2010). Model of colonic inflammation: immune modulatory mechanisms in inflammatory bowel disease. J. Theor. Biol., 264(4), 1225-1239.
64. Wu, G., & Morris, S. M. Jr. (1998). Arginine metabolism: nitric oxide and beyond. Biochem. J., 336, 1-17.
65. Xaus, J., Comalada, M., Valledor, A. F., Lloberas, J., López-Soriano, F., Argilés, J. M., Bogdan, C., & Celada, A. (2000). LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood, 95(12), 3823-3831.